Lack of weight gain during the first two months of treatment and HIV independently predict unsuccessful treatment outcomes in tuberculosis.
Weight change may inform tuberculosis (TB) treatment response, but its predictive power may be confounded by HIV. We prospectively followed adults with culture-confirmed, drug-susceptible, pulmonary TB receiving standard 4-drug therapy (isoniazid, rifampin, pyrazinamide, ethambutol) in Brazil and examined median weight change two months after treatment initiation by HIV status using quantile regression, and unsuccessful TB treatment outcome (treatment failure, TB recurrence, or death) by HIV and weight change status using Cox regression. Among 547 participants, 102 (19%) were HIV-positive, and 35 (6%) had an unsuccessful outcome. After adjusting for confounders, persons living with HIV (PLWH) gained a median 1.3 kg (95% confidence interval (CI): -2.8, 0.1) less than HIV-negative individuals during the first two months of TB treatment. PLWH were at increased risk of an unsuccessful outcome (adjusted HR=4.8, 95% CI: 2.1, 10.9). Weight change was independently associated with outcome, with risk of unsuccessful outcome decreasing 12% (95% CI: 0.81, 0.95) per 1 kg increase. PLWH gained less weight during the first two months of TB treatment, and lack of weight gain and HIV independently predicted unsuccessful TB treatment outcomes. Weight, an easily-collected biomarker, may identify patients who would benefit from alternative treatment strategies.